CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.50
0.00 (0.00%)
Sep 26, 2025, 4:15 PM GMT+1
CRISM Therapeutics Revenue
CRISM Therapeutics had revenue of 25.00K GBP in the twelve months ending June 30, 2025, down -44.44% year-over-year. In the year 2024, CRISM Therapeutics had annual revenue of 25.00K, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
151.85
Revenue / Employee
6.25K
Employees
4
Market Cap
3.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.00K | -20.00K | -44.44% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
CRISM Therapeutics News
- 12 days ago - CRISM Therapeutics Corporation (AMMCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics - The Armchair Trader
- 3 months ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 5 months ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader